Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation

Canna Clinical TrialsLeave a comment

A retrospective chart review was performed on patients certified for medical cannabis use for blepharospasm from September 2015 to May 2016. Ten patients were certified for medical cannabis use. Five met the inclusion criteria, which was any patient with a diagnosis of BEB receiving standard botulinum toxin treatment who had started medical cannabis treatment by a registered distributor within the state, and was contactable by phone. Four patients discontinued use. Three out of four patients (75%) reported symptomatic improvement. Medical cannabis is an accepted therapy for muscle spastic disorders.

Cannabis research may yield new diet drug, Israeli researcher says

Medical News, Cannabis newsLeave a comment

While cannabis science in the U.S. remains heavily politicized and mired in red tape, our international ally, Israel, is racing ahead. On Tuesday, Jan. 16 at 6 p.m., The California Israel Chamber of Commerce, American Friends of Hebrew University, and financial advisors WGD Partners host a V.I.P. cocktail reception and discussion with Dr. Yossi Tam, Director of Cannabinoid Research at…